Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

401 ARTÍCULOS , VIENDO DEL 301 AL 315

[For a new definition of the Alzheimer's disease]

Dubois B.

Rev Neurol (Paris). 2012 Jun;168(6-7):467-8. doi: 10.1016/j.neurol.2012.03.001. Epub 2012 May 2.

Exercise is more effective than diet control in preventing high fat diet-induced β-amyloid deposition and memory deficit in amyloid precursor protein transgenic mice

Maesako M, Uemura K, Kubota M, Kuzuya A, Sasaki K, Hayashida N, Asada-Utsugi M, Watanabe K, Uemura M, Kihara T, Takahashi R, Shimohama S, Kinoshita A.

J Biol Chem. 2012 Jun 29;287(27):23024-33. doi: 10.1074/jbc.M112.367011. Epub 2012 May 4.

[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]

Croisile B, Auriacombe S, Etcharry-Bouyx F, Vercelletto M; National Institute on Aging (u.s.); Alzheimer Association.

Rev Neurol (Paris). 2012 Jun;168(6-7):471-82. doi: 10.1016/j.neurol.2011.11.007. Epub 2012 May 12.

Retinal pathology as biomarker for cognitive impairment and Alzheimer's disease

Ikram MK, Cheung CY, Wong TY, Chen CP.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):917-22. doi: 10.1136/jnnp-2011-301628. Epub 2012 Jun 25.

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot

Hampel H, Lista S, Khachaturian ZS.

Alzheimers Dement. 2012 Jul;8(4):312-36. doi: 10.1016/j.jalz.2012.05.2116.

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study

Palmqvist S, Hertze J, Minthon L, Wattmo C, Zetterberg H, Blennow K, Londos E, Hansson O.

PLoS One. 2012;7(6):e38639. doi: 10.1371/journal.pone.0038639. Epub 2012 Jun 22.

Genome-wide association study of Alzheimer's disease

Kamboh MI, Demirci FY, Wang X, Minster RL, Carrasquillo MM, Pankratz VS, Younkin SG, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative; Jun G, Baldwin C, Logue MW, Buros J, Farrer L, Pericak-Vance MA, Haines JL, Sweet RA, Ganguli M, Feingold E, Dekosky ST, Lopez OL, Barmada MM.

Transl Psychiatry. 2012 May 15;2(5):e117. doi: 10.1038/tp.2012.45.

The imbalance of vascular molecules in Alzheimer's disease

Bell RD.

J Alzheimers Dis. 2012;32(3):699-709. doi: 10.3233/JAD-2012-121060.

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, Elman L, Karlawish J, Chen-Plotkin A, Hurtig HI, Siderowf A, Swenson F, Lee VM, Morris JC, Trojanowski JQ, Soares H; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2012 Aug 28;79(9):897-905. doi: 10.1212/WNL.0b013e318266fa70. Epub 2012 Aug 1.

Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment

Visser PJ, Wolf H, Frisoni G, Gertz HJ.

Biomark Med. 2012 Aug;6(4):365-8. doi: 10.2217/bmm.12.58.

Mild cognitive impairment: a subset of minor neurocognitive disorder?

Geda YE, Nedelska Z.

Am J Geriatr Psychiatry. 2012 Oct;20(10):821-6. doi: 10.1097/JGP.0b013e31826abc00.

Association of the CR1 polymorphism with late-onset Alzheimer's disease in Chinese Han populations: a meta-analysis

Jin C, Li W, Yuan J, Xu W, Cheng Z.

Neurosci Lett. 2012 Oct 3;527(1):46-9. doi: 10.1016/j.neulet.2012.08.032. Epub 2012 Aug 27.

Marking the markers of Alzheimer's: too good to diagnose, too bad to use?

Olah Z, Pakaski M, Janka Z, Kalman J.

Neuropsychopharmacol Hung. 2012 Sep;14(3):165-76.

New criteria for Alzheimer disease and mild cognitive impairment: implications for the practicing clinician

Budson AE, Solomon PR.

Neurologist. 2012 Nov;18(6):356-63. doi: 10.1097/NRL.0b013e31826a998d.

mCiRNA-synaptic crystal ball?

Bredesen D.

Aging (Albany NY). 2012 Nov;4(11):732-3. doi: 10.18632/aging.100511.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias